For Investors

For Investors

Vitiligo affects 0,5 – 1% of the population. The disease is associated with great stigma, having significant social and professional implications. Symptoms are often masked with heavy makeup. The application method is tedious and is difficult to maintain throughout a working day. The social stigma is considerable especially as the disease affects visible areas such as the face and hands. The contrast is further accentuated in individuals with dark pigmentation. In the United States alone, approximately 2.6 million people are affected by vitiligo. Without treatment the symptoms gradually worsen and the disease can cause great hardship to affected patients. It is not unusual that vitiligo leads to complete depigmentation of the patient. Hence there is a high demand for an effective treatment. For investment related material please contact

Contact us

8 + 15 =